SPAC Investing Explained: Blank-Check Companies, Warrants, Redemption Rights, and De-SPAC Risk

Special purpose acquisition companies -- SPACs -- had their defining moment between 2020 and 2021, when more capital was raised through SPAC IPOs than through conventional IPOs. Retail investors flooded in, drawn by the promise of getting in early on the next great company before it went public. A few deals worked. Most did not.

This guide explains exactly how SPACs work mechanically, why the structure systematically favors sponsors over public shareholders, and what to evaluate when one crosses your research radar.

What a SPAC Is

A SPAC is a blank-check company. It has no operations, no products, no revenue, and no employees beyond a small executive team. Its only purpose is to raise money through an IPO and use that capital to acquire an existing private company -- completing what the industry calls a "business combination" or de-SPAC transaction.

The SPAC raises cash at $10 per share. Investors who participate in the IPO are not buying equity in an operating business. They are handing money to a sponsor team that promises to find a worthy acquisition target within two years. If the sponsor fails to close a deal in that time, the SPAC dissolves and investors get their money back.

This structure was designed to give experienced dealmakers a vehicle to bring private companies to public markets more efficiently than a traditional IPO. In practice it became something different: a mechanism for getting pre-revenue companies public at negotiated valuations, often with generous terms for the sponsor and significant dilution for everyone else.

Understanding the mechanics is essential before evaluating any SPAC as a research idea.

Trust Account Mechanics

When a SPAC completes its IPO, the proceeds go directly into a trust account -- not to the sponsor, not to the company's operating budget. The money sits in the trust, invested in short-dated U.S. Treasury securities, and earns interest while the sponsor hunts for a target.

This trust structure is the central investor protection in a SPAC. Public shareholders know with reasonable certainty what their shares are worth: the trust value per share. For a SPAC that raised $10 per share, the trust value climbs gradually above $10 as T-bill interest accumulates. If no deal closes within the deadline, the trust is distributed to shareholders -- $10 plus interest, minus any permitted expenses.

The trust is not accessible to the sponsor for operating purposes beyond a small drawn-down allowance in some structures. This creates the floor: SPAC shares rarely trade significantly below trust value when no deal has been announced, because rational buyers know the downside is bounded by the trust payout.

That floor changes dramatically once a merger target is announced. At that point, the market is pricing the SPAC on the merits of the proposed combination, not on the trust value. The shares can trade above or below $10 depending on how the market assesses the target business.

Warrant Structure

SPAC units -- the shares sold in the IPO -- typically include warrants as an added incentive for early investors. A warrant is the right to buy shares at a fixed price after the merger closes.

The standard warrant structure gives holders the right to purchase shares at $11.50 per share, exercisable beginning 30 days after the business combination closes. The warrants usually have a 5-year expiration window.

For warrants to have value, the post-merger stock must trade above $11.50. If the de-SPAC company trades at $15, warrants are worth approximately $3.50 in intrinsic value. If the stock trades at $9, warrants are worth nothing on an intrinsic basis.

Warrants create meaningful dilution for post-merger shareholders. Each warrant exercised increases the share count, distributing ownership across more shares. If a SPAC issued one warrant for every share in the IPO, and the deal was funded with 20 million shares, warrant exercise could add up to 20 million additional shares -- diluting existing holders accordingly. The math of dilution is one of the most important factors to understand before assessing a de-SPAC stock.

Warrants also trade separately from common shares on public exchanges after the IPO, giving investors a way to take a leveraged position on the post-merger outcome. This leverage cuts both ways. Warrants can return multiples on a successful deal, and they can go to zero on a failed one.

Redemption Rights: The Structural Asymmetry

Redemption rights are the most unusual feature of SPAC investing, and they create an asymmetry that works in favor of IPO investors.

Any SPAC shareholder has the right to redeem their shares for trust value -- roughly $10 per share -- regardless of how they vote on the proposed merger. An investor can vote in favor of the deal, against it, or abstain, and still submit their shares for redemption before the merger closes.

This separation of voting and economic outcome is fundamental. In a traditional shareholder vote, dissenting investors must accept the outcome once a majority approves. In a SPAC, any shareholder who does not like the deal -- or simply wants their capital back -- can exit at trust value.

The practical consequence: SPAC investors who buy shares at or below trust value have limited downside. They can analyze a merger target, decide it is unattractive, and redeem for $10. The cost of being wrong is minimal.

What this creates is a population of investors who are not truly committed to the post-merger story. They are playing an option: if the deal is good, they stay in. If it is bad, they redeem. This explains why SPAC mergers sometimes close with very high redemption rates -- often 80 to 90 percent of public shareholders choosing to take their trust payout -- leaving the combined company with far less cash than projected.

High redemption rates are a warning signal. They indicate that sophisticated investors who evaluated the deal decided the trust payout was more attractive than the equity. Retail investors who bought shares after a target announcement and did not redeem are often left holding a stock with fewer institutional backers and less cash than the deal originally promised.

The Sponsor Promote: Built-In Dilution

Sponsors -- the team that organizes the SPAC, finds the target, and negotiates the deal -- receive compensation through what is called the founder shares or the promote.

The standard structure allocates 20 percent of the post-IPO share count to the sponsor for nominal consideration, typically $25,000 regardless of how large the SPAC is. For a $200 million SPAC that issued 20 million public shares, the sponsor receives approximately 5 million founder shares -- 20 percent of the post-IPO total -- for a cost of $25,000.

The economics of this arrangement are stark. Public investors paid $10 per share. The sponsor paid roughly half a cent per share. The sponsor's break-even point is essentially zero -- meaning the sponsor makes money on almost any outcome where the stock has any value after the merger. Public shareholders need the stock to stay above $10 just to be flat.

Founder shares are typically subject to lockup restrictions after the merger, preventing the sponsor from immediately selling into the market. But once lockups expire, sponsors have strong incentives to sell, adding supply pressure to the stock.

This founder share structure is not a hidden fee -- it is disclosed in the SPAC prospectus. But many retail investors do not read prospectuses, and the 20 percent promote is not prominently featured in the deal announcements that generate press attention. Understanding it changes the fundamental math of SPAC investing.

PIPE Financing

Most SPAC mergers include a concurrent PIPE -- private investment in public equity. A PIPE is a direct offering of shares, typically at $10 each, to institutional investors who commit capital as a condition of the merger closing.

PIPE financing serves a practical function: SPAC mergers often require more cash than the trust alone provides. A target company seeking $500 million in proceeds may be merging with a SPAC that raised $200 million. A $300 million PIPE fills the gap.

But PIPE quality also carries informational value. When a deal is accompanied by PIPE commitments from well-regarded institutional investors -- major asset managers, sector-specialist funds, crossover investors with deep industry expertise -- it indicates that the deal terms survived scrutiny from sophisticated capital allocators.

When a PIPE is assembled from a diverse collection of smaller family offices, hedge funds with short time horizons, and investors without clear domain expertise, the composition tells a different story. Institutions with real conviction in the target are not in the deal at meaningful sizes.

PIPE investors often receive registration rights that allow them to sell publicly once the shares are registered, which typically happens a few months after the merger closes. This creates a predictable overhang: investors who bought at $10 and are sitting on a loss have no incentive to hold, while investors with gains face limited lock-up friction. The resulting selling pressure can suppress post-merger stock prices independent of the underlying business quality.

The De-SPAC Process

The path from SPAC IPO to publicly traded operating company involves several formal steps.

After the sponsor identifies a target and negotiates preliminary terms, the parties execute a letter of intent. This non-binding document outlines the deal structure, valuation, and key conditions.

The sponsor then conducts due diligence on the target -- reviewing financials, legal status, operations, and management -- and a fairness opinion is obtained, typically from an investment bank, attesting that the consideration offered is fair from a financial point of view.

The combined entity files a proxy statement (or registration statement, depending on structure) with the SEC. This document discloses the target's financials, business description, risk factors, and the terms of the proposed combination. Shareholders vote to approve or reject the deal.

If approved and if the cash available after redemptions meets minimum thresholds specified in the merger agreement, the deal closes. The SPAC converts into the operating company, adopts a new ticker symbol, and the former private company begins trading.

The entire process from LOI to close typically takes four to eight months, creating a window during which the announced target's performance and market reception can change significantly.

Post-Merger Performance: What the Data Shows

The performance record of de-SPAC companies is poor relative to comparable public market investments.

Academic studies examining de-SPAC stocks over the period from 2010 through 2022 consistently find median underperformance relative to the broader market in the 12 to 36 months following merger close. Some studies find that the median de-SPAC stock loses 50 percent or more of its value within two years of completing the business combination. The distribution is wide -- a small percentage of deals produce strong returns -- but the median and mean outcomes are negative on an absolute basis and substantially worse than market benchmarks.

The underperformance has several explanations:

First, targets are often pre-revenue or early-revenue companies that entered the SPAC process because they could not meet the financial bar required for a traditional IPO or did not want to endure the IPO price discovery process. Sponsors negotiate valuation directly with the target, without the anchoring effect of public market investor feedback during a roadshow.

Second, the dilution from founder shares, warrants, and PIPE overhang creates structural headwinds. Even a business that executes its plan reasonably well can produce negative stock returns if the share count inflates materially above what was priced in.

Third, the projections embedded in SPAC proxy filings have historically been optimistic. Studies have documented that the financial forecasts targets present to SPAC shareholders in proxy statements consistently overstated actual revenue and earnings in the years following the merger. Companies that go public through SPACs are not subject to the same legal safe harbor restrictions on forward-looking statements that govern traditional IPO prospectuses, which allowed some deal teams to present highly promotional financial models.

The pattern does not mean every SPAC deal fails. But the structural factors described above mean that a SPAC target needs to substantially exceed expectations just to compensate for the dilution and overhang embedded in the deal structure.

When SPACs Can Work

The SPAC structure is not without legitimate purpose. There are categories of situations where it offers real advantages over traditional capital market paths.

Pre-revenue companies with long development timelines can benefit from the ability to negotiate valuation directly with a sponsor rather than face the uncertain price discovery of a traditional IPO. A clinical-stage biotech or a capital-intensive infrastructure company may find that SPAC merger terms provide more certainty and more flexibility in how the business story is presented to investors.

Companies that benefit from the sponsor's specific operational expertise and network are genuinely better positioned for post-merger success. When a technology sector veteran sponsors a SPAC targeting enterprise software companies, the sponsor's contacts, hiring network, and operational guidance can accelerate growth in ways that pure financial capital cannot.

Compressed timelines can matter in competitive situations. A traditional IPO takes months of preparation and is sensitive to market windows. A SPAC merger, once a deal is signed, can close on a more predictable schedule -- relevant for businesses that need capital quickly or prefer certainty over the best possible price.

The SPAC structure also gives private company founders and early investors a defined liquidity path through the combination agreement, which can align incentives in ways that benefit the post-merger company if the team remains engaged.

How to Evaluate a SPAC

Research on any SPAC begins with the prospectus and proxy materials. Both are available on the SEC's EDGAR filing system. Reading them is non-negotiable.

The sponsor track record is the first filter. Has this team successfully completed prior SPAC mergers? What has happened to those companies? Sponsors with a history of completed deals that traded significantly below $10 within two years of merger close are a clear warning signal. Sponsors with established industry networks and operational credibility in the target sector warrant more attention.

Target industry alignment matters more than general deal-making ability. A sponsor team with deep knowledge of healthcare services evaluating a telehealth company is more credible than a generalist financial sponsor assessing the same target. The due diligence process is more likely to surface real issues, and the post-merger guidance network is more likely to be useful.

PIPE composition provides a proxy for institutional conviction. A PIPE anchored by large, long-term investors who have track records of holding positions in the sector indicates that sophisticated capital allocators reviewed the deal and considered the risk-adjusted return attractive. A PIPE assembled quickly from a broad list of smaller investors suggests otherwise.

The trust per share value relative to market price is a critical data point. When SPAC shares trade at a significant premium to trust value before a deal is announced, speculators are bidding on anticipated deal quality. A premium to trust value means the downside floor is no longer $10 -- it is whatever the stock falls to if the deal disappoints or the SPAC dissolves. Buying a SPAC at $12 per share when trust value is $10.20 means accepting real downside risk.

Warrant pricing signals market sentiment. Warrants trading at deep discounts to intrinsic value indicate that the market has limited confidence in the post-merger stock price holding above the $11.50 exercise price. Warrants trading at elevated premiums suggest the opposite.

Equity Rank and De-SPAC Research

Evaluating a post-merger de-SPAC company through a fundamental lens requires the same tools as any other equity analysis: fair value estimation, financial quality assessment, and risk-adjusted comparison against alternatives.

Equity Rank runs each covered company through 19 valuation methods -- including discounted cash flow models, earnings-based multiples, and asset-based approaches -- and aggregates the results into a SAVE score (Safety, Attractiveness, Value, Efficiency) that surfaces where a company lands relative to peers. For de-SPAC companies that have completed their mergers and begun reporting quarterly financials, the platform processes available data and produces model estimates of fair value and financial quality.

Because many de-SPAC companies entered public markets with aggressive growth projections and limited historical data, fundamental analysis requires particular care. Equity Rank's multi-method approach helps identify which valuation frameworks are applicable given a company's stage and financial history, and flags where model confidence is lower due to thin data.

Research on de-SPAC companies is available at equity-rank.com for any ticker with sufficient reported financial history. The SAVE score provides a starting point for further research -- not a directive, but a framework for understanding where the model estimates value relative to the current market price.

The Bottom Line

SPACs are not investments to approach casually. The structure creates real, quantifiable advantages for sponsors -- low cost basis, warrants, and founder shares -- while placing the dilution burden on public shareholders. Post-merger performance data supports skepticism as a starting posture.

That does not mean every SPAC deal is unattractive. Sponsor track record, PIPE quality, target industry fit, and the relationship between market price and trust value are all evaluable factors. The tools for doing that evaluation are the same ones that apply to any equity research process: reading the filings, running the numbers, and comparing the risk-reward against other research ideas.

Self-directed investors who understand the mechanics are better equipped to identify the rare de-SPAC that actually closes the gap between its merger-day valuation and the market's subsequent assessment. They are also better equipped to avoid the many that do not.

Directional accuracy figures referenced in any Equity Rank simulation context are based on historical model testing, not live trading results. No content on this page constitutes investment advice or a recommendation to take any action in any security.